Please complete the CAPTCHA to continue
@casebia.com
✓
3 phones found area 617
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Robin A. Walker is listed as Chief Compliance Officer | Chief Legal Officer | Corporate Secretary | Governance | Risk / Regulatory | M&A | Commercial | Boards | Investor Relations | IPO at Areteia Therapeutics, a company with 32 employees, based in Lexington, Massachusetts, United States. AeroLeads shows a work email signal at casebia.com, phone signal with area code 617, and a matched LinkedIn profile for Robin A. Walker.
Robin A. Walker previously worked as Chief Legal Officer and Corporate Secretary at Areteia Therapeutics and Chief Legal Officer, Chief Compliance Officer, & Corporate Secretary at Goldfinch Bio. Robin A. Walker holds Doctor Of Law - Jd from Boston University School Of Law.
This section adds company-level context without repeating Robin A. Walker's masked contact details.
AeroLeads found 1 current-domain work email signal for Robin A. Walker. Compare company email patterns before reaching out.
As a strategic Executive and Board Member with over 23 years of experience, I navigate compliance, corporate governance, regulatory, risk management, M&A, and IP for publicly traded and privately held biotechnology, pharmaceutical, and retail companies. I’m a trusted member of, and advisor to, boards and executive management teams on collaborations, licensing, M&A, IPOs, venture capital, healthcare, regulatory, U.S. and international compliance, alliance management, business development, executive compensation, U.S. securities laws, corporate communications, and investor relations. - My corporate governance experience spans private and public biopharmaceutical companies such as Areteia Therapeutics, Inc., Goldfinch Bio, Inc., and Stoke Therapeutics, Inc., serving as the Chief Compliance Officer, Chief Legal Officer, and Corporate Secretary and on the Executive Leadership Team. I also led compliance and legal functions, facilitating corporate strategy development at Casebia Therapeutics as part of the Executive Leadership Team.- I negotiated and drafted Biogen’s M&A, asset and stock purchase agreements, including the acquisition of a subsidiary of Neurimmune Holding AG. I represented Novartis Institutes for BioMedical Research in drafting and negotiating stock purchase agreements and collaboration and option agreements with Myogen, Vernalis PLC and other biotechnology companies.- I’ve designed and led corporate communications and public relations strategy and activities, including management of investor relations in collaboration with Casebia Therapeutics Head of Finance. I frequently advise companies transitioning into clinical stage and preparing for IPOs and other strategic financings.- At Areteia Therapeutics, a Phase III company working to develop the first oral therapy to treat eosinophilic asthma, Goldfinch Bio, a Series B precision medicine company, and at Stoke Therapeutics, I have been a key part of leadership teams advising on building and scaling for compliant, cost-effective growth with fit-for-purpose strategies, policies, and procedures. I currently serve on the Board of Directors of Nuvara Therapeutics, a clinical-stage biotech company with a disruptive approach to modulating epithelial transmembrane proteins to treat disease; and the Board of Trustees of the Massachusetts General Hospital. I’m also a member of the Dean’s Advisory Council at Boston University School of Law.
Listed skills include Legal Advice, Corporate Law, Corporate Governance, Commercial Contracts, and 1 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Member of the Areteia Therapeutics Executive Leadership Team and advisor to Board of Directors and board’s Audit, Compensation, and Nominating and Corporate Governance committees. Responsible for development and oversight of compliance and legal functions, including contract management, corporate governance, risk management, IP portfolio and strategy.
Cambridge, Massachusetts, US
Member of Goldfinch Bio Executive Leadership Team and advisor to Board of Directors and the Board’s Audit, Compensation, and Nom/Gov committees. Responsible for development and oversight of compliance and legal functions, including corporate governance, risk management, IP portfolio and strategy, IPO preparedness and SEC filing reviews. Designed scalable.
Bedford, Massachusetts, US
Member of the Stoke Executive Leadership Team and advisor to the Board of Directors, joining shortly after IPO to ensure the company was regulatory compliant as a public company. Responsible for corporate governance; reviewing SEC filings; and oversaw corporate compliance and legal functions, including work of outside corporate and IP counsel, and.
Cambridge, MA, US
Member of the Casebia Executive Leadership Team and advisor to the Board of Directors. Designed and oversaw all aspects of legal strategy and operations, risk management, IP strategy and portfolio, collaborations, licensing, corporate governance, corporate compliance, and corporate policies. Built the legal team and oversaw a multi-million dollar budget..
Cambridge, MA, US
Advised senior management on securities law compliance and fair disclosure, corporate governance, strategic transactions, and business law for the general and administrative functions. Core member of teams leading R&D, alliances, commercialization, lifecycle management, and regulatory matters for late stage products. Served on the promotional review.
Framingham, MA, US
Led team of attorneys and contract specialists in reviewing contracts for Staples' North American Delivery business. Advised on strategy and legal compliance to Executive Leadership Team and senior management for four business units on topics including Federal Acquisition Regulations, Federal Trade Commission Regulations, antitrust issues, IP rights and.
Pittsburgh, Pennsylvania, US
Advised private and public clients on a variety of corporate and securities law matters, including mergers and acquisitions, venture capital and other private equity transactions, public and private securities offerings, Exchange Act reporting, debt financings, and corporate governance issues. Clients included medical device, biotechnology, pharmaceutical.
Quick answers generated from the profile data available on this page.
Robin A. Walker works for Areteia Therapeutics.
Robin A. Walker is listed as Chief Compliance Officer | Chief Legal Officer | Corporate Secretary | Governance | Risk / Regulatory | M&A | Commercial | Boards | Investor Relations | IPO at Areteia Therapeutics.
AeroLeads has found 1 work email signal at @casebia.com for Robin A. Walker at Areteia Therapeutics.
AeroLeads has found 3 phone signal(s) with area code 617 for Robin A. Walker at Areteia Therapeutics.
Robin A. Walker is based in Lexington, Massachusetts, United States while working with Areteia Therapeutics.
Robin A. Walker has worked for Areteia Therapeutics, Goldfinch Bio, Stoke Therapeutics, Casebia Therapeutics, and Biogen.
You can use AeroLeads to view verified contact signals for Robin A. Walker at Areteia Therapeutics, including work email, phone, and LinkedIn data when available.
Robin A. Walker holds Doctor Of Law - Jd from Boston University School Of Law.
Robin A. Walker is listed with skills including Legal Advice, Corporate Law, Corporate Governance, Commercial Contracts, and Intellectual Property.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts